The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary FibrosisStefano Kette, Barbara Ruaro, Lucrezia Mondini et al.|Pharmaceuticals|2025Cited by 6
Comorbidities’ Effect on IPF: Pathogenesis and ManagementAndrea Salotti, Barbara Ruaro, Micol Pividori et al.|Biomedicines|2025Cited by 3